Evaluation of Paracheck-Pf™ rapid malaria diagnostic test for the diagnosis of malaria among HIV-positive patients in Ibadan, South-Western Nigeria

Pathogens and Global Health

Volumn 107, Issue 2, 2013, Pages 69-77

  Falade, Catherine O ^a   Adesina Adewole, B ^a   Dada Adegbola, H O ^a   Ajayi, I O ^a   Akinyemi, J O ^a   Ademowo, O G ^a   Adewole, I F ^a   Kanki, P ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Adult; HIV; Malaria; Paracheck RDT

Indexed keywords

AMODIAQUINE; ARTEMETHER; ARTEMISININ; ARTESUNATE; BENFLUMETOL; CHLOROQUINE; COTRIMOXAZOLE; PYRIMETHAMINE PLUS SULFADOXINE;

ADULT; AGED; ARTICLE; BLOOD SMEAR; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEMATOCRIT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALARIA; MALARIA RAPID TEST; MALE; MICROBIOLOGICAL PARAMETERS; MICROSCOPY; NIGERIA; PARASITE DENSITY; PLASMODIUM FALCIPARUM; PREGNANT WOMAN; PREVALENCE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMODIAQUINE; ANTI-HIV AGENTS; ANTIMALARIALS; CD4 LYMPHOCYTE COUNT; COST-BENEFIT ANALYSIS; FEMALE; GUIDELINES AS TOPIC; HIV SEROPOSITIVITY; HUMANS; MALARIA, FALCIPARUM; MALE; MICROSCOPY; NIGERIA; PREVALENCE; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; WORLD HEALTH ORGANIZATION;

EID: 84875436368     PISSN: 20477724     EISSN: 20477732     Source Type: Journal    
DOI: 10.1179/2047773213Y.0000000077     Document Type: Article

References (54)

1. UNAIDS Data Tables 2011. Available at: http://www.unaids. org/en/media/unaids/contentassets/documents/unaidspublica tion/2011/JC2225_UNAIDS_datatables_en.pdf (accessed 17 February 2013).
2. Abu-Raddad LJ, Patnaik P, Kublin JG. Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science. 2006;314;1603-6.
3. van Geertruyden JP, Menten J, Colebunders R, Korenromp E, D'Alessandro U. The impact of HIV-1 on the malaria parasite biomass in adults in sub-Saharan Africa contributes to the emergence of antimalarial drug resistance. Malar J. 2008;7:134.
4. French N, Nakiyingi J, Lugada E, Watera C, Whitworth JA, Gilks CF. Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults. AIDS. 2001;15:899-906.
5. Korenromp EL, Williams BG, de Vlas SJ, Gouws E, Gilks CF, Ghys PD, et al. Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa. Emerg Infect Dis. 2005;11:1410-9.
6. Goselle ON, Onwuliri CO, Onwuliri VA. Malaria infection in HIV/AIDS patients and its correlation with packed cell volume (PCV). J Vector Borne Dis. 2009;46(3):205-11.
7. Hochman S, Kim K. The impact of HIV and malaria coinfection. What is known and suggested venues for further study. Interdiscip Perspect Infect Dis. 2009;2009:Article ID 617954, 1-8.
8. Reyburn H, Mbatia R, Drakeley C, Carneiro I, Mwakasungula E, Mwerinde O, et al. Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ. 2004;20; 329(7476):1212.
9. Kaplan JE, Masur H, Holmes KK. Guidelines for preventing opportunistic infections among HIV-infected persons-2002 Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep. 2002;51(RR-8):1-52.
10. Adewole OO, Erhabor GE, Ogunrombi AB, Awopeju FA. Prevalence and patient characteristics associated with pleural tuberculosis in Nigeria. J Infect Dev Ctries. 2010;4:213-7.
11. Feikin DR, Jagero G, Aura B, Bigogo GM, Oundo J, Beall BW, et al. High rate of pneumococcal bacteremia in a prospective cohort of older children and adults in an area of high HIV prevalence in rural western Kenya. BMC Infect Dis. 2010;10:186.
12. Watera C, Todd J, Muwonge R, Whitworth J, Nakiyingi-Miiro J, Brink A, et al. Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1-infected adults attending an HIV/AIDS clinic in Uganda. J Acquir Immune Defic Syndr. 2006;42:373-8.
13. WHO. Malaria rapid diagnostic test performance: Results of WHO product testing of malaria RDTs: round 2 (2009). Geneva, Switzerland: WHO, 2010.
14. Chidioni PL, Bowers K, Jorgensen P, Barnwell JW, Grady KK, Luchavez J, et al. The heat stability of Plasmodium lactate dehydrogenase-based and histidine-rich protein 2-based malaria rapid diagnostic tests. Trans R Soc Trop Med Hyg. 2007;101:331-7.
15. WHO. Antimalarial Drug Combination Therapy: Report of a WHO Technical Consultation. WHO/CDS/RBM/2001.35.
16. Kamugisha ML, Msangeni H, Beale K, Malecela EK, Akide J, Ishengoma DR, et al. Paracheck Pf compared with microscopy for diagnosis of Plasmodium falciparum malaria among children in Tanga City, North-eastern Tanzania. Tanzan J Health Res. 2006;10:14-9.
17. Hopkins H, Bebell L, Kambale W, Dokomajilar C, Rosenthal PJ, Dorsey G. Rapid diagnostic tests for malaria at sites of varying transmission intensity in Uganda. J Infect Dis. 2008;197:510-8.
18. Chinkhumba J, Skarbinski J, Chilima B, Campbell C, Ewing V, San Joaquin M, et al. Comparative field performance and adherence to test results of four malaria rapid diagnostic tests among febrile patients more than five years of age in Blantyre, Malawi. Malar J. 2010;9:209.
19. Alam MS, Mohon AN, Mustafa S, Khan WA, Islam N, Karim MJ, et al. Real-time PCR assay and rapid diagnostic tests for the diagnosis of clinically suspected malaria patients in Bangladesh. Malar J. 2011;10:175.
20. Minja DT, Schmiegelow C, Oesterholt M, Magistrado PA, Boström S, John D, et al. Reliability of rapid diagnostic tests in diagnosing pregnancy-associated malaria in north-eastern Tanzania. Malar J. 2012;21:211.
21. Dhorda M, Piola P, Nyehangane D, Tumwebaze B, Nalusaji A, Nabasumba C, et al. Performance of a histidine-rich protein 2 rapid diagnostic test, Paracheck Pf H for detection of malaria infections in Ugandan pregnant women. Am J Trop Med Hyg. 2012;86(1):93-5.
22. British Broadcasting Corporation [Accessed 2010 May 27]. Available from: http://www.bbc.co.uk/weather/world/city_ guides/results.shtml.
23. Salako LA, Ajayi FO, Sowunmi A, Walker, O. Malaria in Nigeria: A revisit. Ann Trop Med Parasitol. 1990;84:435-45.
24. FMOH Federal Ministry of Health, National Malaria and Vector Control Division Abuja-Nigeria. National Malaria Treatment Policy, January 2005.
25. Yusuf OB, Dada-Adegbola HO, Ajayi IO Falade CO. Malaria prevention practices among mothers delivering in an urban hospital in southwest Nigeria. J Vector Borne Dis. 2008;45:217-24.
26. Tongo OO, Orimadegun AE, Akinyinka OO. Utilisation of malaria preventive measures during pregnancy and birth outcomes in Ibadan, Nigeria. BMC Pregnancy Childbirth. 2008;11:60.
27. Oresanya OB, Hoshen M, Sofola OT. Utilization of insecticidetreated nets by under-five children in Nigeria: assessing progress towards the Abuja targets. Malar J. 2008;7:145.
28. Idowu OA, Sam-Wobo SO, Oluwole AS, Adediran AS. Awareness, possession and use of insecticide-treated nets for prevention of malaria in children under five in Abeokuta, Nigerian. J Paediatr Child Health. 2011;47(3):117-21.
29. Onyenekwe CC, Ukibe N, Meludu SC, Ilika A, Aboh N, Ofiaeli N, et al. Prevalence of malaria as co-infection in HIV-infected individuals in a malaria endemic area of south-eastern Nigeria. J Vector Borne Dis. 2007;44:250-4.
30. Falade CO, Nash O, Akingbola TS, Michael OS, Olojede F, Ademowo OG. Evaluation of malaria parasitemia in blood banking in an endemic area. Ann Trop Med Parasitol. 2009;103:383-92.
31. Kamya MR, Gasasira AF, Achan J, Mebrahtu T, Ruel T, Kekitiinwa A, et al. Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV infected Ugandan children. AIDS. 2007;21:2059-66.
32. Nakanjako D, Kiragga AN, Castelnuovo B, Kyabayinze DJ, Kamya MR. Low prevalence of Plasmodium falciparum antigenaemia among asymptomatic HAART-treated adults in an urban cohort in Uganda. Malar J. 2011;10:66.
33. Mishra LC, Bhattacharya A, Sharma M, Bhasin VK. Short report: HIV Protease inhibitors, Indinavir or Nelfinavar, augment antimalarial action of artemisinin in vitro. Am J Trop Med Hyg. 2010;82:148-50.
34. Parikh S, Gut J, Istvan E, Goldberg DE, Havlir DV, Rosenthal PJ. Antimalarial activity of human immunodeficiency virus Type 1 protease inhibitors. Antimicrob Agents Chemother. 2005;49:2983-5.
35. Andrews KT, Fairlie DP, Madala PK, Ray J, Wyatt DM, Hilton PM, et al. Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria. Antimicrob Agents Chemother. 2006;50(2):639-48.
36. Mermin J, Lule JR, Ekwaru JP. Association between malaria and CD4 cell count decline among persons with HIV. J Acquir Immune Defic Syndr. 2006;41:129-30.
37. Mills LA, Kagaayi J, Nakigozi G, Galiwonga RM, Ouma J, Shott JP, et al. Short report: utility of a point-of-care malaria rapid diagnostic test for excluding malaria rapid diagnostic test for excluding malaria as the cause of fever among HIV-positive adults in rural Rakai, Uganda. Am J Trop Med Hyg. 2010;82:145-7.
38. Huong NM, Davis TM, Hewitt S, Van Huong N, Uyen TT, Nhan DH, et al. Comparison of three antigen detection methods for diagnosis and therapeutic monitoring of malaria: a field study from southern Vietnam. Trop Med Int Health. 2002;7:304-8.
39. Abeku TA, Kristan M, Jones C, Beard J, Mueller DH, Okia M, et al. Determinants of the accuracy of rapid diagnostic tests in malaria case management: evidence from low and moderate transmission settings in the East African highlands. Malar J. 2008;7:202.
40. Endeshaw T, Graves PM, Shargie EB, Gebre T, Ayele B, Yohannes G, et al. Comparison of Parascreen Pan/Pf, Paracheck Pf and light microscopy for detection of malaria among febrile patients, Northwest Ethiopia. Trans R Soc Trop Med Hyg. 2010;104:467-74.
41. McMorrow ML, Masanja MI, Kahigwa E, Abdulla SM, Kachur SP. Quality assurance of rapid diagnostic tests for malaria in routine patient care in rural Tanzania. Am J Trop Med Hyg. 2010;82:151-5.
42. Kyabayinze DJ, Tibenderana JK, Odong GW, Rwakimari JB, Counihan H. Operational accuracy and comparative persistent antigenicity of HRP2 rapid diagnostic tests for Plasmodium falciparum malaria in a hyperendemic region of Uganda. Malar J. 2008;7:221.
43. Gerstl S, Dunkley S, Mukhtar A, De Smet M, Baker S, Maikere J, et al. Assessment of two malaria rapid diagnostic tests in children under five years of age, with follow-up of false-positive pLDH test results, in a hyperendemic falciparum malaria area, Sierra Leone. Malar J. 2010;9:28.
44. Bharti PK, Silawat N, Singh PP, Singh MP, Shukla M, Chand G, et al. The usefulness of a new rapid diagnostic test, the First Response Malaria Combo (pLDH/HRP2) card test, for malaria diagnosis in the forested belt of central India. Malar J. 2008;7:126.
45. Mtove G, Nadjm B, Amos B, Hendriksen IC, Muro F, Reyburn H. Use of an HRP2-based rapid diagnostic test to guide treatment of children admitted to hospital in a malariaendemic area of north-east Tanzania. Trop Med Int Health. 2011;16:545-50.
46. Gillet P, Mori M, Van Esbroeck M, Van den Ende J, Jacobs J. Assessment of the prozone effect in malaria rapid diagnostic tests. Malar J. 2009;8:271.
47. Baker J, McCarthy J, Gatton M, Kyle DE, Belizario V, Luchavez J, et al. Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests. J Infect Dis. 2005;192:870-877.
48. Marriette N, Barnadas C, Bouchier C, Tichit M, Ménard D. Country-wide assessment of the genetic polymorphism in Plasmodium falciparum and Plasmodium vivax detected with rapid diagnostic tests for malaria. Malar J. 2008;7: 219.
49. Pava Z, Echeverry DF, Díaz G, Murillo C. Short report: large variation in detection of histidine-rich protein 2 in Plasmodium falciparum isolates from Colombia. Am J Trop Med Hyg. 2010;83(4):834-7.
50. Batwala V, Magnussen P, Nuwaha F. Are rapid diagnostic tests more accurate in diagnosis of Plasmodium falciparum malaria compared to microscopy at rural health centres? Malar J. 2010;9:349.
51. May J, Mockenhaupt FP, Ademowo OG, Falusi AG, Olumese PE, Bienzle U, et al. High rate of mixed and subpatent malarial infections in southwest Nigeria. Am J Trop Med Hyg. 1999;61:339-43.
52. Swarthout TD, Counihan H, Senga RK, van den Broek I. Paracheck-Pf H accuracy and recently treated Plasmodium falciparum infections: is there a risk of over-diagnosis? Malar J. 2007;6:58.
53. Houzé S, Boly MD, Le Baras J, Deloron P, Faucher JF. PfHRP2 and PfLDH for monitoring the efficacy of artemisinin-based combination therapy (ACT) in the treatment of uncomplicated falciparum malaria. Malar J. 2009;8:211.
54. Uzochukwu BSC, Obikeze EN, Onwujekwe OE, Onoka CA, Griffiths UK. Cost-effectiveness analysis of rapid diagnostic test, microscopy and syndromic approach in the diagnosis of malaria in Nigeria: implications for scaling-up deployment of ACT. Malar J. 2009;8:265.